Injectable Benzodiazepine Market

Injectable Benzodiazepine Market By Drug Class (Diazepam, Lorazepam, Midazolam), Time of Action (Short Acting, Long Acting), Indication (Agitation & Aggression, Anxiety, Alcohol Withdrawal, Muscle Spasm), Distribution Channel (Hospital, Ambulatory Surgical centers, Diagnostics Centers) & Region - Forecast to 2022-2032

Market Insights on Injectable Benzodiazepine covering sales outlook, demand forecast and up-to-date key trends

Request Sample

Injectable Benzodiazepines Market Outlook & Key Findings

Injectable benzodiazepines market expected to grow at over 2.7 % in 2020. Increasing adoption of generic injectable benzodiazepine drugs to be a key growth driver
Low profitability margin remains a challenge for injectable benzodiazepines market players
Outbreak of Covid-19 to increase the short-term demand for injectable benzodiazepine drugs as anxiety levels increase in general population
Short-acting injectable benzodiazepines gaining traction

Growing Incidences of Mental Disorders to Drive the Market

Injectable benzodiazepine drugs are administered as the first course of treatment with regards to mental disorders like depression, bipolar disorder, schizophrenia, dementia, anxiety disorder, autism.

The WHO, European Brain Council (EBC), and European College of Neuropsychopharmacology (ECNP) state that around 25% of the global population encounters mental disorders at least once in their lifetime.

As per NSDUH (National Survey on Drug Use and Health), in 2017, close to 46.6 million adults suffered from mental disorders (up by 1.5% in 2010) in the US. So, it could be inferred that 18-20% of the people in the US suffer from mental disorders, which are expected to account for the largest share of injectable benzodiazepines market in the forecast period.

As per the WHO, in the year 2017, around 35-40% of people in the EU were affected with mental disorders. Besides, as of 2015, increase in chronic depression resulted in higher absenteeism coupled with lower productivity at work. This lacuna had cost EU US$47.04 Billion Tn 2015.

On the other hand, India, in 2017, accounted for almost 15% of the global neurological, mental, and substance abuse disorders. In Asia-Pacific on the whole, more than 68% of the people are reported to have psychiatric disorders. This figure is expected to have Asia Pacific witness the highest growth rate in terms of injectable benzodiazepines.

As per the Anxiety and Depression Association of America, around 40 million adults of the US get affected by anxiety disorders every year. The medical fraternity states that the number of mental disorders would increase in the near future due to less attention being paid to self-talk.

All the facts mentioned above are expected to drive the injectable benzodiazepines market in the years to come.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Generics Leading the Injectable Benzodiazepine Market Space Over Lower Price Point

Injectable benzodiazepine market is subject to fierce competition due to increasing adoption of generic injectables that prove to be cost-effective as compared to their branded counterparts. As per the Association of Accessible Medicines, branded drugs account for around 77% of the overall spending on prescriptions with merely 10% of those prescriptions getting filled.

Also, in the year 2017, generics saved close to US$ 265 billion through generics. These generics corresponded to treatment for hypertension, ulcer, cholesterol, and mental health.

Generic diazepam, midazolam, and lorazepam drugs are prescribed for seizures, insomnia, and anxiety. These generic medications are expected to boost the injectable benzodiazepines market in the forecast period.

Injectable Benzodiazepines Market Remains Consolidated

The inorganic modes of expansion include technology and distribution agreements, product improvement, and partnerships. These moves are expected to give an impetus to the market in the forecast period.

For instance – Xeris Pharmaceuticals, in Apr 2020, announced positive results out of their Phase 1b weight-based dosing study regarding diazepam intramuscular (IM) injection by using XeriSol technology.

In Dec, 2019, Eton Pharmaceuticals, Inc. announced commercial availability of Biorphen, an injectable benzodiazepine, for treating hypotension.

“SUBLOCADE”, a buprenorphine extended-release injection, is available in the US since Mar 2018 post approval from the US FDA for treating OUD (opioid use disorder).

Short-Acting Injectable Benzodiazepines Gaining Traction

Increasing demand for short-acting injectable benzodiazepines due to faster excretion and immediate action is resulting in higher level of supervised administration.

Panic disorders are reported to affect around 2.7% of the US population. Muscle spasm and alcohol withdrawal also call for short acting injectable benzodiazepine drugs.

Plus, feasible scenario relating to reimbursement has made these healthcare solutions affable. These measures are expected to upscale the market in the forecast period.

Covid-19 Crisis to Bolster the Market Short-Term

The outbreak of Covid-19 has raised uncertainties, which have led to the onset of various mental disorders.

For instance – in Italy, the basic concern revolves around managing family and children along with maintenance of own borders and spaces. Developing economies like Brazil aren’t getting any active support on the count of addressing mental illnesses. Professional institutions need to come into picture to address this.

In the UK, the worrisome issues include uncertain future, anxiety/stress, and getting bored. Over 63% of the population of the UK is concerned about what is exactly in store for them. This factor is bound to raise the number of cases relating to mental stress.

In countries like India, almost 33% of the entire population has admitted to have a pessimistic impact of Covid-19 as joblessness has set in. Those working on daily wages and also the ones in field jobs have already lost out on their source of income; which is making inroads for depression and anxiety.

In the US, over 30% of people have been reported to get mentally affected by Covid-19. As the future looks bleak, people are getting drawn towards being mentally blank. Along with the professional concerns, there are personal concerns like coping up with the corporate lifestyle. A vacuum is getting created involuntarily; which is adding to the stress.

The factors mentioned above are expected to drive the market for injectable benzodiazepines in the next few months.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Stringent Regulations and Misuse of Injectable Benzodiazepines: Key Challenges to Injectable Benzodiazepines Market

There only a handful of patented injectable benzodiazepines that fall in the “branded” category. As such, procuring and developing the ingredients could prove to be complex. Besides, stringent regulations regarding quality assessment may hamper the market.

Also, intake of these drugs without proper medical advice may prove to be fatal. Since the year 2010, overdose of benzodiazepines has resulted in 6507 deaths in the US. Also, in Sweden, a study was conducted wherein it was revealed that benzodiazepines are the drugs with majority of forged prescriptions.

This factor also proves to be a restraint with respect to the growth of the market.

Injectable Benzodiazepines Market: Region-wise Analysis

Injectable Benzodiazepine Market

North America and Europe hold the largest market share in injectable benzodiazepines mainly due to increasing adoption of generic injectable benzodiazepines. The US is expected to witness around 2.8% growth in 2020. In Latin America, anxiety and alcohol withdrawal symptoms are driving the market and expected to do so in the forecast period as well.

Asia Pacific is witnessing mass production of generic injectable benzodiazepines, which will facilitate its fastest growth rate in the upcoming period. Oceania and MEA are still in the growth phase.

Leading Players in Injectable Benzodiazepines Market

The injectable benzodiazepines market is in the consolidation phase; with 15+ players involved in extensive research and capacity expansion to maintain a strong foothold in the market.

One such study was conducted in Sweden in Apr 2020 to look into the association between paternal and maternal mental disorders with risk of injuries in the adolescents and children. On the similar grounds, a new study by Boston Medical Center revealed that 1 in 3 people receive medication related to opioid use disorder, that too, within a year of non-fatal overdose of the same. Likewise, studies are being conducted across the globe to look for advantages of injectable benzodiazepines and their application in the broader scenario.

The key players in the injectable benzodiazepines market include:

Americas

Pfizer Inc.
Akorn Inc
Dash Pharmaceuticals LLC
AdvaCare Pharma

Europe

Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
F. Hoffmann-La Roche Ltd
Hameln pharma ltd
Teva Pharmaceutical Industries Ltd. (Actavis Pharma, Inc.)
Accord Healthcare Ltd

Asia Pacific

Sun Pharmaceutical Industries Limited
Taj Pharmaceuticals Limited
Troy Laboratories Pty Ltd
Intas Pharmaceuticals Limited
Martin Dow

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report

Injectable Benzodiazepines: The Way Forward

The injectable benzodiazepines market, in the long run, shows optimism, with FMI’s analysis predicting a steady growth rate of 2.7% in the forecast period. Covid-19 pandemic will also see an upswing in the market for the subsequent months. At the same time, growing adoption of generic drugs is another factor providing traction to the market.

The manufacturers are needed to emphasize on production and cost management for addressing drug shortages and also reach out to wider geographies. Auto-injector technology, if put into practice, is bound to reach more number of people within no time. Also, players will have to collaborate with the governments to reform the regulations; so that more such drugs could be tabled.

Key Segments of Injectable benzodiazepines Market

FMI’s study on the injectable benzodiazepines market offers information divided into three important segments— drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

Diazepam
Lorazepam
Midazolam

Time of Action

Short Acting
Long Acting

Indication

Agitation & Aggression
Anxiety
Alcohol Withdrawal
Muscle Spasm
Seizures
Tetanus
Sedation
Anaesthesia
Insomnia
Status Epilepticus

Distribution Channel

Hospital
Ambulatory Surgical centers
Diagnostics Centers

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Frequently Asked Questions

At what rate will the injectable benzodiazepines market grow from 2022 to 2032?

The injectable benzodiazepines market is expected to grow at a 2.7% CAGR from 2022 to 2032

What is the expected market value for the injectable benzodiazepines in 2022?

By 2022-end, injectable benzodiazepines sales are likely to reach US$ 274 Million

What is the expected market value for the injectable benzodiazepines market in 2032?

By 2032-end, injectable benzodiazepines sales are likely to reach US$ 356Million

Which are some leading players in the injectable benzodiazepines market?

Pfizer Inc., Akorn Inc, and Sun Pharmaceutical Industries Limited are some leading injectable benzodiazepines market vendors.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Per Capita Healthcare Expenditure Outlook

4.1.3. Overall Psychoactive Drugs Market

4.2. Forecast Factors - Relevance & Impact

4.2.1. Increasing Incidence of Anxiety, Seizures, Insomnia

4.2.2. Increasing Usage as Anaesthesia

4.2.3. Dose Per Case

4.2.4. Treatment Cost

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

5. Market Context

5.1. Product Adoption / Usage Analysis By Indication

5.2. Disease Epidemiology, By Region

5.3. Regulatory Scenario

5.4. Reimbursement Landscape

5.5. Key Promotional Strategies, By Manufacturers

5.6. COVID19 Crisis Analysis

5.6.1. Current COVID19 Statistics and Probable Future Impact

5.6.2. Current GDP Projection and Probable Impact

5.6.3. COVID19 and Impact Analysis

5.6.3.1. Revenue By Class

5.6.3.2. Revenue By Country

5.6.4. 2020 Market Scenario

5.6.5. Quarter by Quarter Forecast

5.6.6. Projected recovery Quarter

5.6.7. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Injectable Benzodiazepines Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Opportunity Analysis, 2020-2030

7. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, By Drug Class

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Drug Class , 2015–2019

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class , 2020-2030

7.3.1. Diazepam

7.3.2. Lorazepam

7.3.3. Midazolam

7.4. Market Attractiveness Analysis By Drug Class

8. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Indication

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 - 2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 - 2030

8.3.1. Agitation & Aggression

8.3.2. Anxiety

8.3.3. Alcohol Withdrawal

8.3.4. Muscle Spasm

8.3.5. Seizures

8.3.6. Tetanus

8.3.7. Sedation

8.3.8. Local Anaesthesia

8.3.9. Insomnia

8.3.10. Status Epilepticus

8.4. Market Attractiveness Analysis By Indication

9. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, By Time of Action

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Time of Action, 2014 - 2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Time of Action, 2019 - 2030

9.3.1. Short Acting

9.3.2. Long Acting

9.4. Market Attractiveness Analysis By Time of Action

10. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2030

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Mail Order Pharmacies/Online Pharmacies

10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Region

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa

11.4. Market Attractiveness Analysis By Region

12. North America Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Drug Class

12.3.3. By Indication

12.3.4. By Time of Action

12.3.5. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Key Market Participants - Intensity Mapping

12.6. Drivers and Restraints - Impact Analysis

13. Latin America Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Drug Class

13.3.3. By Indication

13.3.4. By Time of Action

13.3.5. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Key Market Participants - Intensity Mapping

13.6. Drivers and Restraints - Impact Analysis

14. Europe Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Drug Class

14.3.3. By Indication

14.3.4. By Time of Action

14.3.5. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Key Market Participants - Intensity Mapping

14.6. Drivers and Restraints - Impact Analysis

15. South Asia Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Drug Class

15.3.3. By Indication

15.3.4. By Time of Action

15.3.5. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Key Market Participants - Intensity Mapping

15.6. Drivers and Restraints - Impact Analysis

16. East Asia Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Drug Class

16.3.3. By Indication

16.3.4. By Time of Action

16.3.5. By Distribution Channel

16.4. Market Attractiveness Analysis

16.5. Key Market Participants - Intensity Mapping

16.6. Drivers and Restraints - Impact Analysis

17. Oceania Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Drug Class

17.3.3. By Indication

17.3.4. By Time of Action

17.3.5. By Distribution Channel

17.4. Market Attractiveness Analysis

17.5. Key Market Participants - Intensity Mapping

17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. By Drug Class

18.3.3. By Indication

18.3.4. By Time of Action

18.3.5. By Distribution Channel

18.4. Market Attractiveness Analysis

18.5. Key Market Participants - Intensity Mapping

18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. U.S. Injectable Benzodiazepines Market Analysis

19.2.1. By Drug Class

19.2.2. By Indication

19.2.3. By Time of Action

19.2.4. By Distribution Channel

19.3. Canada Injectable Benzodiazepines Market Analysis

19.3.1. By Drug Class

19.3.2. By Indication

19.3.3. By Time of Action

19.3.4. By Distribution Channel

19.4. Mexico Injectable Benzodiazepines Market Analysis

19.4.1. By Drug Class

19.4.2. By Indication

19.4.3. By Time of Action

19.4.4. By Distribution Channel

19.5. Brazil Injectable Benzodiazepines Market Analysis

19.5.1. By Drug Class

19.5.2. By Indication

19.5.3. By Time of Action

19.5.4. By Distribution Channel

19.6. U.K. Injectable Benzodiazepines Market Analysis

19.6.1. By Drug Class

19.6.2. By Indication

19.6.3. By Time of Action

19.6.4. By Distribution Channel

19.7. Germany Injectable Benzodiazepines Market Analysis

19.7.1. By Drug Class

19.7.2. By Indication

19.7.3. By Time of Action

19.7.4. By Distribution Channel

19.8. France Injectable Benzodiazepines Market Analysis

19.8.1. By Drug Class

19.8.2. By Indication

19.8.3. By Time of Action

19.8.4. By Distribution Channel

19.9. Italy Injectable Benzodiazepines Market Analysis

19.9.1. By Drug Class

19.9.2. By Indication

19.9.3. By Time of Action

19.9.4. By Distribution Channel

19.10. Spain Injectable Benzodiazepines Market Analysis

19.10.1. By Drug Class

19.10.2. By Indication

19.10.3. By Time of Action

19.10.4. By Distribution Channel

19.11. BENELUX Injectable Benzodiazepines Market Analysis

19.11.1. By Drug Class

19.11.2. By Indication

19.11.3. By Time of Action

19.11.4. By Distribution Channel

19.12. Russia Injectable Benzodiazepines Market Analysis

19.12.1. By Drug Class

19.12.2. By Indication

19.12.3. By Time of Action

19.12.4. By Distribution Channel

19.13. China Injectable Benzodiazepines Market Analysis

19.13.1. By Drug Class

19.13.2. By Indication

19.13.3. By Time of Action

19.13.4. By Distribution Channel

19.14. Japan Injectable Benzodiazepines Market Analysis

19.14.1. By Drug Class

19.14.2. By Indication

19.14.3. By Time of Action

19.14.4. By Distribution Channel

19.15. South Korea Injectable Benzodiazepines Market Analysis

19.15.1. By Drug Class

19.15.2. By Indication

19.15.3. By Time of Action

19.15.4. By Distribution Channel

19.16. India Injectable Benzodiazepines Market Analysis

19.16.1. By Drug Class

19.16.2. By Indication

19.16.3. By Time of Action

19.16.4. By Distribution Channel

19.17. ASEAN Injectable Benzodiazepines Market Analysis

19.17.1. By Drug Class

19.17.2. By Indication

19.17.3. By Time of Action

19.17.4. By Distribution Channel

19.18. Australia Injectable Benzodiazepines Market Analysis

19.18.1. By Drug Class

19.18.2. By Indication

19.18.3. By Time of Action

19.18.4. By Distribution Channel

19.19. New Zealand Injectable Benzodiazepines Market Analysis

19.19.1. By Drug Class

19.19.2. By Indication

19.19.3. By Time of Action

19.19.4. By Distribution Channel

19.20. GCC Countries Injectable Benzodiazepines Market Analysis

19.20.1. By Drug Class

19.20.2. By Indication

19.20.3. By Time of Action

19.20.4. By Distribution Channel

19.21. Turkey Injectable Benzodiazepines Market Analysis

19.21.1. By Drug Class

19.21.2. By Indication

19.21.3. By Time of Action

19.21.4. By Distribution Channel

19.22. South Africa Injectable Benzodiazepines Market Analysis

19.22.1. By Drug Class

19.22.2. By Indication

19.22.3. By Time of Action

19.22.4. By Distribution Channel

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players

20.3. Market Presence Analysis

20.3.1. Regional Footprint by Players

20.3.2. Product Foot print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Pfizer Inc.

21.3.1.1. Overview

21.3.1.2. Product Portfolio

21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

21.3.1.4. Sales Footprint

21.3.1.5. Strategy Overview

21.3.1.5.1. Marketing Strategy

21.3.1.5.2. Product Strategy

21.3.1.5.3. Channel Strategy

21.3.2. Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

21.3.2.1. Overview

21.3.2.2. Product Portfolio

21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

21.3.2.4. Sales Footprint

21.3.2.5. Strategy Overview

21.3.2.5.1. Marketing Strategy

21.3.2.5.2. Product Strategy

21.3.2.5.3. Channel Strategy

21.3.3. Taj Pharmaceuticals Limited

21.3.3.1. Overview

21.3.3.2. Product Portfolio

21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

21.3.3.4. Sales Footprint

21.3.3.5. Strategy Overview

21.3.3.5.1. Marketing Strategy

21.3.3.5.2. Product Strategy

21.3.3.5.3. Channel Strategy

21.3.4. Accord Healthcare Ltd

21.3.4.1. Overview

21.3.4.2. Product Portfolio

21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

21.3.4.4. Sales Footprint

21.3.4.5. Strategy Overview

21.3.4.5.1. Marketing Strategy

21.3.4.5.2. Product Strategy

21.3.4.5.3. Channel Strategy

21.3.5. Dash Pharmaceuticals LLC

21.3.5.1. Overview

21.3.5.2. Product Portfolio

21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

21.3.5.4. Sales Footprint

21.3.5.5. Strategy Overview

21.3.5.5.1. Marketing Strategy

21.3.5.5.2. Product Strategy

21.3.5.5.3. Channel Strategy

21.3.6. hameln pharma ltd

21.3.6.1. Overview

21.3.6.2. Product Portfolio

21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

21.3.6.4. Sales Footprint

21.3.6.5. Strategy Overview

21.3.6.5.1. Marketing Strategy

21.3.6.5.2. Product Strategy

21.3.6.5.3. Channel Strategy

21.3.7. F. Hoffmann-La Roche Ltd

21.3.7.1. Overview

21.3.7.2. Product Portfolio

21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

21.3.7.4. Sales Footprint

21.3.7.5. Strategy Overview

21.3.7.5.1. Marketing Strategy

21.3.7.5.2. Product Strategy

21.3.7.5.3. Channel Strategy

21.3.8. AdvaCare Pharma

21.3.8.1. Overview

21.3.8.2. Product Portfolio

21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

21.3.8.4. Sales Footprint

21.3.8.5. Strategy Overview

21.3.8.5.1. Marketing Strategy

21.3.8.5.2. Product Strategy

21.3.8.5.3. Channel Strategy

21.3.9. Troy Laboratories Pty Ltd

21.3.9.1. Overview

21.3.9.2. Product Portfolio

21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

21.3.9.4. Sales Footprint

21.3.9.5. Strategy Overview

21.3.9.5.1. Marketing Strategy

21.3.9.5.2. Product Strategy

21.3.9.5.3. Channel Strategy

21.3.10. Martin Dow

21.3.10.1. Overview

21.3.10.2. Product Portfolio

21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

21.3.10.4. Sales Footprint

21.3.10.5. Strategy Overview

21.3.10.5.1. Marketing Strategy

21.3.10.5.2. Product Strategy

21.3.10.5.3. Channel Strategy

21.3.11. Sun Pharmaceutical Industries Limited

21.3.11.1. Overview

21.3.11.2. Product Portfolio

21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

21.3.11.4. Sales Footprint

21.3.11.5. Strategy Overview

21.3.11.5.1. Marketing Strategy

21.3.11.5.2. Product Strategy

21.3.11.5.3. Channel Strategy

21.3.12. Intas Pharmaceuticals Limited

21.3.12.1. Overview

21.3.12.2. Product Portfolio

21.3.12.3. Profitability by Market Segments (Product/Channel/Region)

21.3.12.4. Sales Footprint

21.3.12.5. Strategy Overview

21.3.12.5.1. Marketing Strategy

21.3.12.5.2. Product Strategy

21.3.12.5.3. Channel Strategy

21.3.13. Teva Pharmaceutical Industries Ltd. (Actavis Pharma, Inc.)

21.3.13.1. Overview

21.3.13.2. Product Portfolio

21.3.13.3. Profitability by Market Segments (Product/Channel/Region)

21.3.13.4. Sales Footprint

21.3.13.5. Strategy Overview

21.3.13.5.1. Marketing Strategy

21.3.13.5.2. Product Strategy

21.3.13.5.3. Channel Strategy

21.3.14. Akorn Inc

21.3.14.1. Overview

21.3.14.2. Product Portfolio

21.3.14.3. Profitability by Market Segments (Product/Channel/Region)

21.3.14.4. Sales Footprint

21.3.14.5. Strategy Overview

21.3.14.5.1. Marketing Strategy

21.3.14.5.2. Product Strategy

21.3.14.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables

Table 01: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Drug Class

Table 02: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Indication

Table 03: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Time of Action

Table 04: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Distribution Channel

Table 05: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region

Table 06: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 07: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 08: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 09: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 10: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 11: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 12: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 13: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 14: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 15: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 16: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 17: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 18: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 19: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 20: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 21: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 22: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 23: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 24: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 25: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 26: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 27: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 28: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 29: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 30: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 31: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 32: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 33: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 34: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 35: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 36: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 37: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 38: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 39: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 40: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Injectable Benzodiazepines Market Value Share, By Drug Class, 2019 (A)

Figure 02: Global Injectable Benzodiazepines Market Value Share, By Indication, 2019 (A)

Figure 03: Global Injectable Benzodiazepines Market Value Share, By Time of Action, 2019 (A)

Figure 04: Global Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2019 (A)

Figure 05: Global Injectable Benzodiazepines drugs Market Value Analysis 2015-2021 & 2030

Figure 06: Global Injectable Benzodiazepines drugs Market Y-O-Y Growth Analysis By Region

Figure 07: Global Injectable Benzodiazepines Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)

Figure 08: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019

Figure 09: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030

Figure 10: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Drug Class, 2020 & 2030

Figure 11: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Drug Class, 2020–2030

Figure 12: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020–2030

Figure 13: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Indication, 2020 & 2030

Figure 14: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Indication, 2020–2030

Figure 15: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020–2030

Figure 16: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Time of Action, 2020 & 2030

Figure 17: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Time of Action, 2020–2030

Figure 18: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020–2030

Figure 19: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Distribution Channel, 2020 & 2030

Figure 20: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2020–2030

Figure 21: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020–2030

Figure 22: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Region, 2020 & 2030

Figure 23: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 24: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Region, 2020–2030

Figure 25: North America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 26: North America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 27: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 28: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 29: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 30: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 31: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 32: Latin America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 33: Latin America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 34: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 35: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 36: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 37: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 38: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 39: Europe Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 40: Europe Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 41: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 42: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 43: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 44: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 45: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 46: South Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 47: South Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 48: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 49: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 50: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 51: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 52: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 53: East Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 54: East Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 55: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 56: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 57: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 58: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 59: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 60: Oceania Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 61: Oceania Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 62: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 63: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 64: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 65: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 66: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 67: MEA Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 68: MEA Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 69: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 70: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 71: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 72: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 73: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 74: US Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 75: US Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 76: US Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 77: US Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 78: Canada Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 79: Canada Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 80: Canada Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 81: Canada Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 82: Australia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 83: Australia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 84: Australia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 85: Australia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 86: New Zealand Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 87: New Zealand Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 88: New Zealand Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 89: New Zealand Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 90: GCC Countries Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 91: GCC Countries Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 92: GCC Countries Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 93: GCC Countries Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 94: South Africa Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 95: South Africa Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 96: South Africa Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 97: South Africa Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 98: Turkey Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 99: Turkey Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 100: Turkey Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 101: Turkey Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 102: China Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 103: China Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 104: China Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 105: China Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 106: Japan Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 107: Japan Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 108: Japan Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 109: Japan Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 110: South Korea Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 111: South Korea Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 112: South Korea Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 113: South Korea Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 114: India Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 115: India Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 116: India Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 117: India Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 118: ASEAN Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 119: ASEAN Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 120: ASEAN Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 121: ASEAN Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 122: Germany Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 123: Germany Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 124: Germany Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 125: Germany Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 126: Italy Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 127: Italy Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 128: Italy Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 129: Italy Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 130: France Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 131: France Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 132: France Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 133: France Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 134: U.K. Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 135: U.K. Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 136: U.K. Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 137: U.K. Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 138: Spain Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 139: Spain Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 140: Spain Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 141: Spain Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 142: BENELUX Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 143: BENELUX Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 144: BENELUX Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 145: BENELUX Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 146: Russia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 147: Russia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 148: Russia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 149: Russia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 150: Brazil Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 151: Brazil Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 152: Brazil Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 153: Brazil Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 154: Mexico Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 155: Mexico Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 156: Mexico Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 157: Mexico Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)